PREV — Preveceutical Medical Balance Sheet
0.000.00%
- CA$13.64m
- CA$17.94m
Annual balance sheet for Preveceutical Medical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.028 | 0.156 | 0.016 | 0.006 | 0.001 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.096 | 0.091 | 0.055 | 0.019 | 0.005 |
Prepaid Expenses | |||||
Total Current Assets | 0.288 | 0.263 | 0.083 | 0.063 | 0.064 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.454 | 0.009 | 0.002 | 0.001 | 0.001 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.858 | 0.302 | 0.161 | 0.189 | 0.182 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.83 | 2.03 | 2.59 | 4.82 | 5.96 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 5.34 | 3.91 | 4.27 | 4.82 | 5.96 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | -4.49 | -3.6 | -4.1 | -4.64 | -5.78 |
Total Liabilities & Shareholders' Equity | 0.858 | 0.302 | 0.161 | 0.189 | 0.182 |
Total Common Shares Outstanding |